Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Ovation Science Inc.

Market Cap 576K 411K 357K 329K 308K 39.39M 588K 3.93M 1.52M 18.99M 1.54M 1.51M 66.03M P/E Ratio 2024
-2.68x
P/E Ratio 2025 -2.26x
Enterprise Value 787K 562K 488K 450K 421K 53.81M 803K 5.36M 2.08M 25.94M 2.11M 2.06M 90.18M EV / Sales 2024
13.2x
EV / Sales 2025 25.7x
Free-Float
76.54%
Yield 2024 *
-
Yield 2025 -
1 day-53.95%
3 months+65.09%
6 months+18.64%
Current year+18.64%
Current year 0.02
Extreme 0.0212
0.08
1 year 0.01
Extreme 0.0136
0.08
3 years 0
Extreme 0.0025
0.12
5 years 0
Extreme 0.0023
0.16
10 years 0
Extreme 0.0023
0.48
Manager TitleAgeSince
Director of Finance/CFO 63 2023-10-29
Chief Executive Officer 77 2017-10-03
Director TitleAgeSince
Director/Board Member 77 2017-10-03
Director/Board Member 63 2017-10-03
Director/Board Member 86 2018-02-01
Change 5-day change 1-year change 3-year change Capi.($)
-53.95%-.--% - - 414K
-0.20%+3.34%+1.32%-4.70% 237B
+1.14%+5.91%+48.11% - 48.99B
0.00%+1.36%+201.84% - 10.11B
+1.46%+0.93%+5.43%-61.12% 6.3B
0.00%+0.54%-19.97%+4.29% 4.54B
-2.28%-4.63%-25.57%-41.81% 3.76B
+4.40%+17.96%-51.27%-41.94% 3.45B
+1.82%+12.68%-28.87%-25.18% 3.15B
-0.75%+3.37%-24.21%-50.02% 2.57B
Average -4.84%+4.89%+11.87%-31.50% 35.53B
Weighted average by Cap. +0.09%+3.38%+13.23%-7.63%

Financials

2024 2025
Net sales 113K 80.84K 70.16K 64.67K 60.59K 7.74M 116K 771K 299K 3.73M 303K 297K 12.97M 67.89K 48.48K 42.07K 38.78K 36.33K 4.64M 69.3K 463K 179K 2.24M 182K 178K 7.78M
Net income -456K -326K -283K -261K -244K -31.19M -466K -3.11M -1.2M -15.04M -1.22M -1.2M -52.28M -631K -451K -391K -361K -338K -43.16M -644K -4.3M -1.67M -20.8M -1.69M -1.66M -72.34M
Net Debt 265K 189K 164K 151K 142K 18.13M 271K 1.81M 700K 8.74M 711K 695K 30.39M 211K 151K 131K 120K 113K 14.41M 215K 1.44M 556K 6.95M 565K 553K 24.15M
Logo Ovation Science Inc.
Ovation Science Inc. is a Canada-based drug development company. The Company develops topical and transdermal cannabidiol (CBD)/ tetrahydrocannabinol (THC) and other cannabinoid products which are out-licensed and also distributed under its own brands; ARLO CBD Beauty and InVibe MD (wellness line); all powered by its patented Invisicare skin delivery technology. The Company manufactures, distributes, sells, markets, sub-licenses and promotes products formulated with Invisicare, containing cannabinoids, hemp seed oil or synthetic derivatives of cannabis. The Company has developed topical and transdermal creams and lotions made with CBD, THC and combinations thereof plus hemp seed oil. Invisicare is a patented polymer-based technology for topical and transdermal skincare products. ARLO CBD Beauty offers science-based skincare solutions. Invibe MD offers a health and wellness product line infused with hemp-derived CBD and developed using Invisicare drug delivery technology.
Employees
-
Date Price Change Volume
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!